STERIS plc (STE) Form 144: proposed sale of 15,000 shares
STERIS plc received a Form 144 notice for a proposed sale of 15,000 Ordinary shares.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
STERIS plc received a Form 144 notice for a proposed sale of 15,000 Ordinary shares. The filing lists an aggregate market value of $3,977,050 and an approximate sale date of 11/11/2025. The designated broker is Charles Schwab & Co., Inc., and the shares are to be sold on the NYSE.
The shares were acquired on 11/11/2025 via an employee stock option exercise with a broker payment for cashless exercise. This notice reflects an intended disposition by a holder under Rule 144.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did STERIS plc (STE) disclose in this Form 144?
A proposed sale of 15,000 Ordinary shares under Rule 144 with an aggregate market value of $3,977,050.
Which broker and exchange are identified?
Charles Schwab & Co., Inc. is the broker, and the shares are to be sold on the NYSE.
What is the aggregate market value of the proposed sale?
The filing states an aggregate market value of $3,977,050.
What class of securities is involved for STE?
The filing covers Ordinary shares of STERIS plc.
AI-generated analysis. How Rhea-AI works. Not financial advice.